1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nephrin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nephrin) | Trials (nephrin) | Recent Studies (post-2010) (nephrin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,130 | 9 | 621 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amore, A; Balegno, S; Bussolati, B; Camilla, R; Camussi, G; Coppo, R; Fonsato, V; Loiacono, E; Peruzzi, L; Ricotti, E | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nephrin
Article | Year |
---|---|
Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes.
Topics: Adolescent; Adult; Case-Control Studies; Cells, Cultured; Child; Culture Media, Conditioned; Fluorescent Antibody Technique, Indirect; Glycosylation; Humans; Immunoglobulin A; Membrane Proteins; Mesangial Cells; Platelet Activating Factor; Podocytes; Young Adult | 2010 |